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Introduction
Angiotensin I-converting enzyme (ACE)' (kininase II, EC 3.4.15.1) is widely distributed in the body. Its major recognized functions are the conversion of angiotensin I to the vasoactive, antinatriuretic octapeptide angiotensin II, and the inactivation of kinins, which have vasodilator and natriuretic properties (1) . ACE is an ectoenzyme located in the plasma membrane of various types of cells, including endothelial cells of all vascular beds, cells of absorptive epithelia such as the renal proximal tubule, and other epithelia, including those in the brain, with particularly high concentrations in the choroid plexus, and is also found in biological fluids such as plasma and cerebrospinal fluid (2) .
Plasma ACE concentration is stable in a given individual, but varies between different subjects (3) and displays an intrafamilial correlation that is contributed by a major gene effect (4) . ACE is encoded by a 21-kb, 26 exon gene (5) located on chromosome 17 at q23 (6) . A polymorphism of the ACE gene has been described and involves the insertion/deletion of a 287-bp Alu repetitive sequence, in reverse orientation, near the 3' end of intron 16 (7, 8) . Plasma (7) and tissue (9) ACE concentration has been found to track with the deletion (D) allele of the IID polymorphism, such that plasma values are DD > ID > II, and the polymorphism is itself a neutral marker for a yet-to-beidentified closely linked variant responsible for level of ACE activity in plasma (10) .
In a recent case-control study, the frequency of the DD genotype was found to be elevated in geographically separated populations of French and Irish Caucasian patients who had had a myocardial infarction (MI) (11) . That the DD genotype contributes to fatal events, rather than nonfatal events or survival of MI, was supported by a subsequent report of association with parental history of fatal MI (12) . Since then, other groups have reported an elevation in DD genotype frequency in 101 MI patients from Japan (13), as well as in 112 Caucasian patients with idopathic-dilated cardiomyopathy (14), 102 with ischemic-dilated cardiomyopathy (14), 25 with hypertrophic cardiomyopathy who had a strong family history of sudden cardiac death (15) , and 32 Japanese patients with restenosis after emergency percutaneous transluminal angioplasty (16) .
In the Cambien study, the prevalence of hypertension (HT) and the blood pressure (BP) of a control, non-MI group was similar for each I/D genotype (11) . Because many of their MI patients were receiving drugs likely to affect BP, Cambien et al. were unable to define a normotensive (NT) low-risk group and so did not test whether DD frequency was higher, the same, or lower with respect to this particular risk factor by itself. In relation to other risk factors, however, they found DD genotype was especially frequent in MI patients regarded as low-risk according to their BMI and plasma ApoB or total cholesterol, but for high-and low-risk groups defined according to median cigarette consumption results were similar. Thus the finding of higher DD in MI patients formerly considered to be at low risk according to common criteria was demonstrated for some of the common risk factors, but BP was not tested. A possible 
Methods
Subjects. These were 118 Caucasian HTs who had two HT parents and a control group of 196 NT subjects whose parents were NT past the age of 50 yr. Virtually all were volunteers. Further details of ascertainment and other information have been described previously (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) . Table I shows demographic parameters for each group. Diastolic blood pressures (DBPs) of all HTs were . 100 mmHg and of all NTs were < 90 mmHg. Age distribution of HTs (22-82 yr: male, 22-69; female, 26-82) and NTs (30-71 yr) was similar: For the age groups < 50, 50-59 and 2 60 yr, proportions of subjects were 46, 19, and 35%, respectively, for HTs, and were 65, 26, and 15% for NTs. In the HT group there were no males older than 69, whereas there were 7 females.
All of the HTs had been diagnosed with HT prior to age 54, the mean being 32±7 SD yr and was similar for each age group and IID genotype. Among NTs, death from heart attack would be less than the rate of 0.1% for the population as a whole in the age range of our control group (19), since the risk factor of "hypertension" was absent. Given that death from heart attack in Australians aged 60-70, far exceeds that in younger age groups (19), < 1% of a NT group aged < 71 yr would have been expected to have died of heart attack, which for a group of 196 subjects would represent < 2 individuals, i.e., would be undetectable. We noticed, moreover, that < 10% of HTs had two HT parents, as would be expected for a disease that affects 1 in 5 adults, since the chance of any person having two HT parents would be 1/5 x 1/5 x 1/ 2 = 1 in 50, i.e., 2% of adults, or 10% of HTs. Thus our HT study population was a select subset.
Materials and experimental protocols. Genotypes for the I/D polymorphism were determined as described previously (8, 22) . Plasma ACE activity and ACE kinetic measurements were made using an ACE activity radioassay kit (Hycor Biomed. Inc., Portland, ME), with substrate concentrations for the kinetic assays being set at 1.6, 3.2, 4.8, 6.4, and 8.0 ,mol/ml.
Statistical analyses. Genotype data were assigned to each age group and values for each age category in the NT group were then tested for deviation from those for the NT group as a whole by x2 analysis. Once it was established that no significant difference existed, the values for the whole of the NT group were then compared, in the same way, with values for each age category of the HT group.
Results
Allele frequencies in different age groups. In the NT group, D allele frequency was similar for each age group, viz. 0.59, 0.68, and 0.64 in subjects aged < 50, 50-59 and 2 60 yr, respectively (X2 < 0.5, P > 0. 5 In sharp contrast to results for the NT group, I/D allele, and genotype frequencies of each age group of HTs showed either no significant difference (< 50 yr-old age group), a small statistical difference (50-59 yr-old age group), or a highly significant difference (2 60 yr-old age group) when compared by x2 analysis to values for the whole of the NT group (Table II) . Furthermore, x2 analysis of DD frequency of each age group between the HT and NT groups also showed a significant difference (X2 2 d.f. = 15.5, P = 0.03).
Allele frequencies for polymorphisms at 12 other loci studied previously (20, 21, (23) (24) (25) (26) (27) (28) (29) showed no change with age in either the NT or HT group (data not shown). In addition, genotype frequencies for these variants obeyed Hardy-Weinberg equilibrium in both the NT and HT groups, with the exception of one which has been shown previously to be associated with HT (21, 26, 29 (Fig. 1) . In the case of Caucasian HTs the relationship of plasma ACE with lID genotype has not previously been examined by others. Our results showed that there was an almost identical pattern of tracking in the HTs examined as was observed in our NT group (Fig. 1) . Moreover, mean plasma ACE was similar between the HT and NT groups and showed no correlation with BP (data not shown), whereas SBP and DBP 100 so _~~~~~NT 10 .6±1.6 SE ,Imol/ml (n = 9) and for II subjects was 11.1+2.3 (n = 10) (P = 0.9 by t test).
Relationship ofI/D genotype with otherparameters. By oneway ANOVA, values for SBP, DBP, BMI, and plasma lipids in each age group were similar across the three lID genotypes of HTs. Two-way ANOVA showed an absence of any relationship between sex and SBP or DBP for the different genotypes for the whole of the HT group, nor for any of the various age groups. Moreover, multiple regression analysis indicated no relationship of BP or BMI with age in any of the genotypes. There was, moreover, no apparent sex difference with respect to the decrease with age in DD frequency seen in the HTs, although the numbers of DD patients were small. Finally, BPs were similarly high in each age group and genotype of HTs.
Discussion
A population in Hardy-Weinberg equilibrium for a particular polymorphism should display genotype frequencies that remain stable throughout life. Any decrease observed for a particular genotype may suggest that alleles for that genotype carry an increased risk of mortality past the age of reproduction. The present cross-sectional study found an apparent age-dependent decrease in DD frequency in a group of patients with severe, familial HT. It would be interesting if this apparent effect could be demonstrated by using the alternative approach of longitudinal analysis. However, this would take many years and could raise ethical concerns in view of the availability of ACE inhibitors that might offset any deleterious consequences arising in HTs as a consequence of having a DD genotype.
It is unlikely that the results were a consequence of older HTs having a different form of HT, such as late-onset HT.
Change in ACE Genotype Frequency with Age 1087 Eo CL Indeed, as described earlier, HT in all patients was in fact of early onset. This also argues against II being associated with a late-onset form of HT. In fact, no evidence has been produced by others for linkage (30) or association (11, 31, 32) of the ACE gene with HT and in the present study BP was similar for each lID genotype, whereas in the case of an unrelated gene in the present group, patients homozygous for a HT-associated variant had higher BP (29) . The present study did not address the question of cause of death of patients carrying the DD genotype, nor could it, since we only studied living individuals. However, since HT was equally severe for patients of each genotype, on average BP by itself should have presented a similar cardiovascular risk to each genotypic subcategory. It is, however, impossible to say whether or not BP and/or plasma ACE were even higher in DD HTs who were not included in the study because of their proposed early death.
Although plasma ACE correlates with BP in children (10), in whom it is claimed genetic effects may be easier to discern because of their higher rate of ACE synthesis (4, 9), we could find no such correlation in the adult subjects used in our study. The present findings for HTs thus extend earlier observations of a lack of correlation of BP with ACE genotype in NT adults (10) . The implication is that DD genotype is either not associated with higher circulating angiotensin II, or the pressor effects of raised angiotensin II in DD patients may have been ameliorated by counterregulatory vasodilator and/or natriuretic mechanisms. Effects on parameters other than BP could, however, be occurring at a more localized level, in regional vascular beds of DD/high ACE patients.
We also found that Km of the ACE encoded by each allelic form of the gene was similar, so that variations in plasma ACE activity for the different genotypes are more likely to reflect differences in the concentration of ACE protein in plasma, as would result from differences in rate of synthesis or release by its cellular source. If it is correct that the present results reflect an increased death rate amongst DD HTs, then coronary heart disease must be considered as a possible candidate, as it accounts for 26% of all deaths in Australia (19). This possibility is, moreover, supported by findings of higher DD frequency in MI patients (11, 13) , those with a family history of fatal MI (12, 17) , and in patients with related cardiac pathologies (14-16). The (11) (12) (13) (14) (15) (16) (17) (18) , but, in apparent contradiction, a recent study has reported the unexpected finding of elevated DD frequency in centenarians (35) . In an attempt to reconcile the latter finding with emerging knowledge, these authors suggested that, in spite of being a risk factor for a leading cause of mortality, the DD genotype might confer some early selective advantage, and the association with longevity may indicate a late reversal of its purported negative survival value. It has also been suggested that effects of higher ACE on myocardial cell growth could increase the incidence of MI and yet allow the left ventricle of a select few to carry them into advanced age (36). It was also suggested that involvement of ACE in a wide range of cellular functions may produce, in noncardiac tissues, beneficial effects that would have survival value should the person not succumb to a cardiac event. For example, higher ACE might improve repair of damaged tissues or increase resistance to neoplasia or infection via metabolism of peptides involved in the inflammatory response or antigen recognition (37) . A further proposal is that the DD variant may have a beneficial effect in neurones of the aged or could be serving as a marker for a hypothetical variant at the linked growth hormone gene locus that could perhaps have relevance to senescence (38). Another possibility is that DD/high ACE might have interactions with variants at other genetic loci that are also needed for an effect on overall death rate. Thus ACE may have both beneficial and deleterious functions, and the balance between each may change during the human lifetime.
In conclusion, this study has found a markedly reduced number of DD genotypes among older HTs, possibly suggesting that homozygosity for the D allele of the ACE gene might be associated with increased risk of premature death, at least in patients with severe, familial HT living in Sydney, who were not selected for cardiac pathology.
